Ortho Regenerative Technologies received an EU Notice of Allowance from the European Patent Office for Patent Application Number 10831000.4, Novel Forumulation of Physiological Chitosan-Inorganic Salt Solution/Blood Mixtures for Tissue Repair. When issued, the patent will protect the composition of Ortho-R biopolymer material for the biologic repair of tissue.
This derives from the company’s second series of patent applications for its propriety biopolymer platform, globally. Ortho-R is in development for the repair of rotator cuff tendons, meniscus and articular cartilage. The polymer can be directly placed into an injury site during a routine procedure, reportedly without significant additional time of the surgery.
Ortho Regenerative Technologies received an EU Notice of Allowance from the European Patent Office for Patent Application Number 10831000.4, Novel Forumulation of Physiological Chitosan-Inorganic Salt Solution/Blood Mixtures for Tissue Repair. When issued, the patent will protect the composition of Ortho-R biopolymer material for the biologic...
Ortho Regenerative Technologies received an EU Notice of Allowance from the European Patent Office for Patent Application Number 10831000.4, Novel Forumulation of Physiological Chitosan-Inorganic Salt Solution/Blood Mixtures for Tissue Repair. When issued, the patent will protect the composition of Ortho-R biopolymer material for the biologic repair of tissue.
This derives from the company’s second series of patent applications for its propriety biopolymer platform, globally. Ortho-R is in development for the repair of rotator cuff tendons, meniscus and articular cartilage. The polymer can be directly placed into an injury site during a routine procedure, reportedly without significant additional time of the surgery.
Copy to clipboard 
